Noopept

CognitiveDipeptide nootropic / researchExperimental

Noopept is a dipeptide nootropic in the Neuromodulator class. Noopept is a proline-containing dipeptide structurally related to the racetam class. It is metabolised in part to cycloprolylglycine, an endogenous dipeptide reported to modulate AMPA and NMDA receptor function.

Calculate Dose

For research use only.

Key Facts

CAS
157115-85-0
Molecular Weight (MW)
318.4 g/mol
Half-life
โ€”
FDA status
Not Approved
Administration Route
oral, intranasal
Frequency
โ€”
Last updated
Aug 30, 2026
Reviewed
Aug 30, 2026

Research summary

Synthetic dipeptide developed in Russia and marketed there as a nootropic. It is not FDA-approved and is not a lawful dietary supplement ingredient in the United States. Most published research is Russian-language and preclinical.

Peptide Library's Noopept profile summarises 5 cited studies listed in the Science section, the compound's regulatory status, and research-protocol parameters reported for it. It is a research reference, not medical advice.

Protocol

Dosage Range
โ€”
Frequency
โ€”
Cycle
โ€”
Administration Route
oral, intranasal
Reconstitution Guide
โ€”

Sequence & molecular data

Sequence and molecular data for Noopept
Molecular formulaC17H22N2O4
Molecular weight318.4 g/mol
CAS number157115-85-0
PubChem CID180496
FDA UNII4QBJ98683M
ChEMBLCHEMBL4303687

Identifiers link to the public PubChem, FDA Substance Registration (UNII), ChEMBL and DrugBank records for the same entity.

Science

Mechanism of Action

Noopept is a proline-containing dipeptide structurally related to the racetam class. It is metabolised in part to cycloprolylglycine, an endogenous dipeptide reported to modulate AMPA and NMDA receptor function. Preclinical studies describe increased expression of brain-derived neurotrophic factor and nerve growth factor in the hippocampus, and antioxidant effects; controlled human efficacy data outside Russia is essentially absent.

Regulatory & research status

Noopept is not an FDA-approved product. It is sold for laboratory research and has no approved medical use.

Regulatory and research status for Noopept
FDA statusNot Approved
Research statusResearch-only compound; no approval pathway listed
AvailabilityResearch-Only
WADA (sport)Unknown / Not Listed
Library classificationResearch-Only

Benefits

โ€”

Potential Side Effects

No side effects listed yet for this entry.

Storage & stability

Lyophilized (freeze-dried) peptide powder is far more stable than the reconstituted solution. Keep sealed vials cold, dry and away from light; long-term storage is typically frozen, with short-term refrigeration for vials in use.

Once reconstituted in bacteriostatic water, keep the solution refrigerated, avoid repeated freezeโ€“thaw cycles and agitation, and label the vial with the reconstitution date and concentration. Discard any solution that turns cloudy or shows particulates.

Degradation rates differ by sequence: peptides containing methionine, cysteine, asparagine or glutamine are more prone to oxidation and deamidation, so shelf life after reconstitution is compound-specific rather than universal.

Read the full guide: how to store peptides before and after reconstitution โ†’

Source: Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544โ€“575. (PMID 20143256). General guidance for research handling; not product-specific instructions.

Noopept: frequently asked questions

What is Noopept?

Synthetic dipeptide developed in Russia and marketed there as a nootropic. It is not FDA-approved and is not a lawful dietary supplement ingredient in the United States. Most published research is Russian-language and preclinical.

How does Noopept work?

Noopept is a proline-containing dipeptide structurally related to the racetam class. It is metabolised in part to cycloprolylglycine, an endogenous dipeptide reported to modulate AMPA and NMDA receptor function.

Is Noopept FDA approved?

No. Noopept is not approved by the FDA for any indication and is categorised as research-only. It has not been reviewed for safety or efficacy as a medicine, and published research should be read as investigation rather than established use.

What peptides are similar to Noopept?

Compounds most often compared with Noopept include Selank, N-Acetyl Selank Amidate, Semax and Tuftsin. They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

References

Related research, comparisons & guides

Related peptides

Compiled by Peptide Library Editorial ยท Reviewed Aug 30, 2026 ยท Updated Aug 30, 2026 ยท Version 2

This Noopept profile is compiled from published literature (5 cited studies linked above), public regulatory records and chemical registries. It describes what research reports; it is not medical advice, and nothing here is a dosing recommendation for humans. Peptide Library does not sell peptides. Editorial policy ยท How profiles are compiled ยท Report an error

Track Noopept research, inventory and reconstitution in the free Peptide Library app. Get the app for iOS or Android โ†’